Komori
Share Issuance and Disposal9267Genky DrugStores Co.,Ltd.Retail

Partial Revision to the "Notice Concerning the Issuance of Stock Options (Share Acquisition Rights)"

For the previously announced stock options, the number of eligible allottees has changed from 204 to 211. The total of 1,000 share acquisition rights, the number of shares subject to the rights at 100,000, and other issuance terms remain unchanged.

Worth reading
41Recurring
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
7
people
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of Stock Options (Stock Acquisition Rights)

Who receives how much

100,000 of the Company's common shares (1,000 share acquisition rights)

The Company's inside directors (excluding directors who are Audit and Supervisory Committee members), and directors and employees of the Company's subsidiaries, 211 people, 1,000 rights

The lower thin line represents the existing number of shares to which these shares will be added.

Terms of the stock acquisition rights
Exercise price
Only the calculation method is stated; the specific exercise price and adjustment provisions are Not disclosed
Number of Stock Acquisition Rights
Total issued: 1,000 rights; unexercised balance: Not disclosed
Categories and Number of Persons Covered
The Company's inside directors (excluding directors who are Audit and Supervisory Committee members), and directors and employees of the Company's subsidiaries, totaling 211 people and 1,000 rights. The number of people and shares by category is Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of Stock Options (Stock Acquisition Rights)
Number of shares to be issued or disposed of100,000 of the Company's common shares (1,000 share acquisition rights)
Intended allotteeThe Company's inside directors (excluding directors who are Audit and Supervisory Committee members), and directors and employees of the Company's subsidiaries, 211 people, 1,000 rights
Exercise priceOnly the calculation method is stated; the specific exercise price and adjustment provisions are Not disclosed
Number of Stock Acquisition RightsTotal issued: 1,000 rights; unexercised balance: Not disclosed
Categories and Number of Persons CoveredThe Company's inside directors (excluding directors who are Audit and Supervisory Committee members), and directors and employees of the Company's subsidiaries, totaling 211 people and 1,000 rights. The number of people and shares by category is Not disclosed
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Additional eligible recipients were selected from among the employees of the Company's subsidiaries, and the allocation of rights among recipients was reviewed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Partial Revision to the "Notice Concerning the Issuance of Stock Options (Share Acquisition Rights)" | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori